Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (831-840 of 1,418) with videos related to

Pageof 142
Sort By:
European Heart Journal. Acute Cardiovascular Care|February 24, 2021
Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromesValentina A Rossi, Andrea Denegri, Alessandro Candreva, et al.
Circulation. Cardiovascular Interventions|August 28, 2019
Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY StentsDean J Kereiakes, Stephan Windecker, R Lee Jobe, et al.
JACC. Cardiovascular Interventions|August 19, 2019
Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical PracticeChristian Zanchin, Yasushi Ueki, Thomas Zanchin, et al.
Journal of Cardiovascular Electrophysiology|April 30, 2021
Efficacy and safety of ethanol infusion into the vein of Marshall for mitral isthmus ablationAnna Lam, Thomas Küffer, Lukas Hunziker, et al.
Journal of the American College of Cardiology|September 4, 2019
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)Konstantinos C Koskinas, Stephan Windecker, Giovanni Pedrazzini, et al.
European Journal of Preventive Cardiology|April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromesBaris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Lancet (London, England)|September 6, 2014
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialThomas Pilgrim, Dik Heg, Marco Roffi, et al.
European Heart Journal|September 4, 2014
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography studyLorenz Räber, Masanori Taniwaki, Serge Zaugg, et al.
Journal of the American College of Cardiology|July 10, 2007
Thrombosis and drug-eluting stents: an objective appraisalDavid R Holmes, Dean J Kereiakes, Warren K Laskey, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 12, 2018
One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trialPatrick W Serruys, Rodrigo Modolo, Michael Reardon, et al.
Pageof 142

Showing results (831-840 of 1,418) with videos related to

Sort By:
Pageof 142
European Heart Journal. Acute Cardiovascular Care|February 24, 2021
Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromesValentina A Rossi, Andrea Denegri, Alessandro Candreva, et al.
Circulation. Cardiovascular Interventions|August 28, 2019
Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY StentsDean J Kereiakes, Stephan Windecker, R Lee Jobe, et al.
JACC. Cardiovascular Interventions|August 19, 2019
Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical PracticeChristian Zanchin, Yasushi Ueki, Thomas Zanchin, et al.
Journal of Cardiovascular Electrophysiology|April 30, 2021
Efficacy and safety of ethanol infusion into the vein of Marshall for mitral isthmus ablationAnna Lam, Thomas Küffer, Lukas Hunziker, et al.
Journal of the American College of Cardiology|September 4, 2019
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)Konstantinos C Koskinas, Stephan Windecker, Giovanni Pedrazzini, et al.
European Journal of Preventive Cardiology|April 10, 2021
Prognostic value of total testosterone levels in patients with acute coronary syndromesBaris Gencer, Nicolas Vuilleumier, David Nanchen, et al.
Lancet (London, England)|September 6, 2014
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialThomas Pilgrim, Dik Heg, Marco Roffi, et al.
European Heart Journal|September 4, 2014
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography studyLorenz Räber, Masanori Taniwaki, Serge Zaugg, et al.
Journal of the American College of Cardiology|July 10, 2007
Thrombosis and drug-eluting stents: an objective appraisalDavid R Holmes, Dean J Kereiakes, Warren K Laskey, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 12, 2018
One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trialPatrick W Serruys, Rodrigo Modolo, Michael Reardon, et al.
Pageof 142